rare parkinsonian syndrome due to neurodegenerative disease
ORPHA: 3066661 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| L-DOPA | Tablet, Capsule | FDA Approved | 4 | — |
Classification & Codes
Orphanet Code
ORPHA:306666rare parkinsonian syndrome due to neurodegenerative disease
| Orphanet | ORPHA:306666 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO